Teva and Amgen Settle Over Kidney Disease Patent Infringement – 24/7 Wall St.
Teva and Amgen Settle Over Kidney Disease Patent Infringement 24/7 Wall St. Teva Pharmaceutical shares made a handy gain on Thursday after it was announced that the firm has settled with Amgen for its treatment of secondary …